NeoGenomics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
NeoGenomics, Inc. (NEO) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$139.69 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2019-02-26
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$3.52M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$2.30M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$4.86M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$3.01M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was -$139.69M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$13.69M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$6.50M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$75.16M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$139.69M 10-K · filed 2019-02-26 | |||
| 2017-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$5.83M derived: sum of 2 quarters · filed 2019-02-26 | -$10.68M derived: sum of 3 quarters · filed 2019-02-26 | -$13.69M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$7.16M derived: sum of 2 quarters · filed 2017-11-13 | -$10.17M 10-Q · filed 2017-11-13 | -$11.34M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$7.86M 10-Q · filed 2017-08-07 | -$9.04M derived: sum of 3 quarters · filed 2019-02-26 | -$10.94M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$3.01M 10-Q · filed 2017-05-09 | -$4.18M derived: sum of 2 quarters · filed 2019-02-26 | -$6.08M derived: sum of 3 quarters · filed 2019-02-26 | -$8.51M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$3.08M derived: sum of 2 quarters · filed 2019-02-26 | -$5.50M derived: sum of 3 quarters · filed 2019-02-26 | -$6.50M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$4.33M derived: sum of 2 quarters · filed 2017-11-13 | -$5.33M 10-Q · filed 2017-11-13 | -$78.80M derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$3.42M 10-Q · filed 2017-08-07 | -$76.90M derived: sum of 3 quarters · filed 2018-03-13 | -$77.40M derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | -$1.00M 10-Q · filed 2017-05-09 | -$74.47M derived: sum of 2 quarters · filed 2018-03-13 | -$74.98M derived: sum of 3 quarters · filed 2018-03-13 | -$75.31M derived: sum of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | -$73.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$73.97M derived: sum of 2 quarters · filed 2018-03-13 | -$74.31M derived: sum of 3 quarters · filed 2018-03-13 | -$75.16M 10-K · filed 2018-03-13 |
| 2015-09-30 | -$502.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$840.00K derived: sum of 2 quarters · filed 2016-11-07 | -$1.68M 10-Q · filed 2016-11-07 | -$2.74M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$1.18M 10-Q · filed 2016-08-05 | -$2.23M derived: sum of 3 quarters · filed 2017-03-14 | -$8.82M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$842.00K 10-Q · filed 2016-05-10 | -$1.90M derived: sum of 2 quarters · filed 2017-03-14 | -$8.48M derived: sum of 3 quarters · filed 2017-03-14 | -$9.56M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$7.64M derived: sum of 2 quarters · filed 2017-03-14 | -$8.72M derived: sum of 3 quarters · filed 2017-03-14 | -$9.60M 10-K · filed 2017-03-14 |
| 2014-09-30 | -$6.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$7.67M derived: sum of 2 quarters · filed 2015-11-06 | -$8.55M 10-Q · filed 2015-11-06 | -$9.07M derived: sum of 4 quarters · filed 2016-04-18 |
| 2014-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$1.97M 10-Q · filed 2015-07-31 | -$2.49M derived: sum of 3 quarters · filed 2016-04-18 | -$3.37M derived: sum of 4 quarters · filed 2016-04-18 |
| 2014-03-31 | -$883.00K 10-Q · filed 2015-05-11 | -$1.41M derived: sum of 2 quarters · filed 2016-04-18 | -$2.29M derived: sum of 3 quarters · filed 2016-04-18 | -$2.65M derived: sum of 4 quarters · filed 2016-04-18 |
| 2013-12-31 | -$525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-18 | -$1.40M derived: sum of 2 quarters · filed 2016-04-18 | -$1.77M derived: sum of 3 quarters · filed 2016-04-18 | -$2.01M 10-K · filed 2016-04-18 |
| 2013-09-30 | -$878.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$1.25M derived: sum of 2 quarters · filed 2014-11-04 | -$1.49M 10-Q · filed 2014-11-04 | |
| 2013-06-30 | -$369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | -$608.00K 10-Q · filed 2014-07-29 | ||
| 2013-03-31 | -$239.00K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | -$3.65M 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |